A medicine for treating cerebrovascular disease

Abstract

The invention relates to a medicine used for curing the cerebrovascular disease. The invention is characterized in that the invention is made of red sage root, rhizome of Sichuan lovage, pangolin, rhizome of king solomonseal, atractylodes macrocephala, Chinese angelica root, astragalus root, panax pseudo to ginseng, cimicifuga rhizome, dried leech, earth worm, cow horn, dried body of scorpion andbatryticated silkworm, the percentages of weight ranged are respectively 15 to 30, 10 to 15, 9 to 15, 10 to 15, 9 to 15, 10 to 15, 15 to 30, 3 to 9, 6 to 9, 2.5 to 5, 6 to 10, 10 to 15, 3 to 6 and 4.5 to 10 in sequence. The medicine of the invention has the functions of stimulating circulation to end stasis, clearing and activating the channels and collaterals, and improving the blood circulationand the blood rheological property and is used for the apoplexia caused by the phlegm-stasis in channels, with the manifestations of numb limbs and tense tendons, dizziness and blurred vision, disturbance of speech, deviation of mouth and eye, sluggish look, facial hemiparalysis and hemiplegia, and sudden clouding collapse; and also the medicine is used for the ischemic cerebral embolism, the cerebrovascular arteriosclerosis, and the cerebral hemorrhage sequela, and the medicine can recover the cerebral blood flow, promote the recovery of paralysis, and improve the quality of life and survival.

Description

technical field [0001] The invention relates to a medicine capable of treating cerebrovascular diseases through three administration routes. Background technique [0002] Cerebrovascular disease is a common and frequently-occurring disease in neurology. 50-70% of the survivors are left with severe disabilities such as paralysis and aphasia, which brings a heavy burden to society and families. Cerebrovascular diseases are divided into ischemic and hemorrhagic. It belongs to the category of stroke, hemiplegia, and hemiplegia of the motherland's medicine. At present, the drugs for treating cerebrovascular diseases mainly include thrombolytics, anticoagulants, brain tissue protective agents and brain metabolic drugs; traditional Chinese medicine mostly uses oral decoctions or Chinese patent medicines (such as cerebral thrombosis tablets) for syndrome differentiation of hemiplegia. Clinical applications have strict treatment "time windows" and contraindications, or the scope of...

AI Technical Summary

Problems solved by technology

In most ischemic cerebrovascular diseases, the inevitable death of nerve cells is the main cause of difficulty in achieving satisfactory curative effect

For the sequelae of cerebrovascular disease, there is currently no effective treatment